Figure 9. LINC01296 regulates MSI2 to participate in the development of TC via the AKT/STAT3 signaling pathway by competitively binding to miR-143-3p.

Silencing LINC01296 could down-regulate MSI2, thus blocking the AKT/STAT3 signaling pathway, inhibiting TC cell proliferation and enhancing TC cell apoptosis.